Sachin C. Narwadiya Research Scholar, School of Public Health, Poornima University, Jaipur 303905, Rajasthan, India
Neha Suthar Research Scholar, Department of Biochemistry, Sai Tirupati University, Udaipur 313003, Rajasthan, India
Address for correspondence: Sachin C. Narwadiya, Research Scholar, School of Public Health, Poornima University, Jaipur 303905, Rajasthan, India E-mail: snarwadiya@gmail.com
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Suthar N, Narwadiya SC. Corona survivors and risk of cardiovascular disease. RFP J Bio Biophy. 2023;8(1):17-21.
Timeline
Received : March 07, 2023
Accepted : June 03, 2023
Published : June 30, 2023
Abstract
After surviving from corona extra care of health is requisite in the society. The news of deaths during exercise in Gym were popular as many celebrities and famous personalities lost their lives. Many of them were corona survivors and post corona excessive exercises lead them to death. The present review study is analyzing the facts lying behind the cause of cardiovascular diseases CVDs. The CVDs increasing death rates in India at fast pace.
References
1. Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021. https://doi. org/10.1001/jama.2021.5469.
2. Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome.Circulati on.2020;141(23):1903–14. https://doi.org/10.1161/ Circulationaha.120.047349.
3. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–55. https:// doi.org/10.1161/Circulationaha.120.046941.
4. Khan MS, Shahid I, Anker SD, Solomon SD, Vardeny O, Michos ED, et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020;18(1):403. https://doi.org/10.1186/s12916-020-01816-2.
5. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8. https://doi. org/10.1001/jamacardio.2020.1017.
6. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC Basic Transl Sci. 2020;5(5):518–36. https://doi. org/10.1016/j.jacbts.2020.04.002.
7. Usman MS, Siddiqi TJ, Khan MS, Ahmed A, Ali SS, Michos ED, et al. A Meta-analysis of the relationship between renin-angiotensin-aldosterone system inhibitors and COVID-19. Am J Cardiol. 2020;130:159–61. https://doi.org/10.1016/j. amjcard.2020.05.038
8. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–73. https://doi.org/10.1001/ jamacardio.2020.3557.
9. Goerlich E, Minhas AS, Mukherjee M, Sheikh FH, Gilotra NA, Sharma G, et al. Multimodality imaging for cardiac evaluation in patients with COVID-19. CurrCardiol Rep. 2021;23(5):44. https://doi. org/10.1007/s11886-021-01483-6.
10. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e51. https://doi.org/10.1161/ CIR.0000000000000617
11. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345 53. https://doi.org/10.1056/NEJMoa1702090.
12. Chapman AR, Bularga A, Mills NL. High sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation. 2020;141(22):1733–5. https://doi.org/10.1161/ Circulationaha.120.047008
13. Jaffe AS, Cleland JGF, Katus HA. Myocardial injury in severe COVID-19 infection. Eur Heart J. 2020;41(22):2080–2. https://doi.org/10.1093/ eurheartj/ehaa447.
14. Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342–53. https:// doi.org/10.1161/Circulationaha.120.047971
15. Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020;106(19):1512–8. https://doi.org/10.1136/ heartjnl-2020-317322
16. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article - Acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis. 2020;63(5):682–9. https://doi.org/10.1016/j. pcad.2020.05.013.
17. Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and myocardial injury in COVID-19: diagnosis, risk stratification and prognosis. Diagnostics. 2021;11(1). https://doi.org/10.3390/ diagnostics11010130.
18. Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, et al. Myocardial injury in severe COVID-19 compared with non-COVID-19 acute respiratory distress syndrome. Circulation. 2021;143(6):553–65. https://doi.org/10.1161/ Circulationaha.120.050543
19. Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2043–55. https://doi. org/10.1016/j.jacc.2020.08.069.
20. La Gerche A, Taylor AJ, Prior DL. Athlete’s heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging. 2009;2(3):350–63. https://doi. org/10.1016/j.jcmg.2008.12.011.
21. Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010;56(3):169–76. https://doi. org/10.1016/j.jacc.2010.03.037.
22. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980 2006. Circulation. 2009;119(8):1085–92. https:// doi.org/10.1161/Circulationaha.108.804617.
23. Phelan D, Kim JH, Chung EH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020;5:1085–6. https://doi.org/10.1001/ jamacardio.2020.2136.
24. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273–80. https://doi. org/10.1161/CIR.0000000000000239.
25. Kim JH, Levine BD, Phelan D, Emery MS, Martinez MW, Chung EH, et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219–27. https://doi.org/10.1001/ jamacardio.2020.5890.
26. Phelan D, Kim JH, Elliott MD, Wasfy MM, Cremer P, Johri AM, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: An Expert Consensus Statement. JACC Cardiovasc Imaging. 2020;13(12):2635–52. https://doi.org/10.1016/j.jcmg.2020.10.005.
27. Radtke T, Crook S, Kaltsakas G, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev 2019;
29. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377–381.
30. Ding D, del Pozo Cruz B, Green MA, Bauman AE. Is the COVID-19 lockdown nudging people to be more active: a big data analysis. Br J Sports Med 2020;54:1183–1184.
31. Tison GH, Avram R, Kuhar P, Abreau S, Marcus GM, Pletcher MJ, Olgin JE. Worldwide effect of COVID-19 on physical activity: a descriptive study. Ann Intern Med 2020;173:767–770.
32. Bhatia RT, Marwaha S, Malhotra A, Iqbal Z, Hughes C, Börjesson M, Niebauer J, Pelliccia A, Schmied C, Serratosa L, Papadakis M, Sharma S. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the Section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2020;27:1242–1251.
33. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020;30:doi:10.1177/204748732 0913379.
34. Chong WF, Ding YY, Heng BH. A comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumonia. BMC Health Serv Res 2011;11:105.
35. Scherrenberg M, Wilhelm M, Hansen D, et al. The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020;2:doi:10.1177/ 2047487320939671.
36. Boldrini, P.; Bernetti, A.; Fiore, P.; SIMFER Executive Committee. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine physicians’ activities in Italy. An official document of the Italian PRM Society (SIMFER). Eur. J. Phys. Rehabil. Med. 2020, 56, 316–318.
37. Blair, J.; Corrigall, H.; Angus, N.J.; Thompson, D.R.; Leslie, S. Home versus hospital-based cardiac rehabilitation: A systematic review. Rural Remote Health 2011, 11, 1532.
38. Clark, R.A.; Conway, A.; Poulsen, V.; Keech, W.; Tirimacco, R.; Tideman, P. Alternative models of cardiac rehabilitation: A systematic review. Eur. J. Prev. Cardiol. 2015, 22, 35–74.
39. Scalvini, S.; Zanelli, E.; Comini, L.; Tomba, M.D.; Troise, G.; Giordano, A. Home-based exercise rehabilitation with telemedicine following cardiac surgery. J. Telemed. Telecare 2009, 15, 297–301.
40. Busch, C.; Baumbach, C.; Willemsen, D.; Nee, O.; Gorath, T.; Hein, A.; Scheffold, T. Supervised training with wireless monitoring of ECG, blood pressure and oxygen-saturation in cardiac patients. J. Telemed. Telecare 2009, 15, 112–114.
41. Piotrowicz, E.; Piepoli, M.F.; Jaarsma, T.; Lambrinou, E.; Coats, A.J.; Schmid, J.P.; Corra, U.; Agostoni, P.; Dickstein, K.; Seferovic, P.M.; et al. Telerehabilitation in heart failure patients: The evidence and the pitfalls. Int. J. Cardiol. 2016, 220, 408–413.
42. Sumner, J.; Harrison, A.; Doherty, P. The effectiveness of modern cardiac rehabilitation: A systematic review of recent observational studies in non-attenders versus attenders. PLoS ONE 2017, 12, e0177658.
43. Luisi, M.L.; Biffi, B.; Gheri, C.F.; Sarli, E.; Rafanelli, E.; Graziano, E.; Vidali, S.; Fattirolli, F.; Gensini, G.F.; Macchi, C. Efficacy of a nutritional education program to improve diet in patients attending a cardiac rehabilitation program: Outcomes of a one-year follow-up. Intern. Emerg. Med. 2015, 10, 671–676.
44. Scalvini, S.; Zanelli, E.; Comini, L.; Tomba, M.D.; Troise, G.; Giordano, A. Home-based exercise rehabilitation with telemedicine following cardiac surgery. J. Telemed. Telecare 2009, 15, 297–301.
Data Sharing Statement
There are no additional data available
Funding
This research received no funding
Author Contributions
All authors contributed significantly to the work and approve its publication
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval
Acknowledgements
Information Not Provided
Conflicts of Interest
No conflicts of interest in this work
About this article
Cite this article
Suthar N, Narwadiya SC. Corona survivors and risk of cardiovascular disease. RFP J Bio Biophy. 2023;8(1):17-21.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.